HLS Therapeutics Inc. announced that at its AGM held on June 16, 2023, the shareholders elected Christian Roy as director.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.45 CAD | -0.58% |
|
-0.86% | -12.66% |
07-02 | National Bank on DRI Healthcare Trust's Xenpozyme Royalty Stream Acquisition | MT |
07-02 | HLS Therapeutics Sells Xenpozyme Royalty Interest to DRI Healthcare Trust | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.66% | 80.12M | |
+26.74% | 75.74B | |
-4.62% | 23.24B | |
+15.24% | 8.76B | |
-33.02% | 6.69B | |
+20.88% | 5.58B | |
+3.71% | 4.22B | |
-3.66% | 3.99B | |
+14.24% | 3.39B | |
+8.74% | 3.23B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- HLS Therapeutics Inc. Elects Christian Roy as Director